Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 28 for “"surrogate endpoints"”.
-
Bayesian evaluation of surrogate endpoints.
… and reduce the size and cost of clinical trials, surrogate endpoints are frequently measured instead of true endpoints. The proportion of the treatment effect explained by surrogate endpoints (PTE) is a widely used, albeit controversial, validation criteria. Frequentist and Bayesian methods have …
-
Evaluation of Potential Surrogate Endpoints
Valid surrogate endpoints can make clinical trials more efficient, allowing for more trials to be conducted and more rapid development of effective treatments. Identifying useful surrogates is a statistically challenging but extremely valuable endeavor. This work develops statistical methods for …
-
Surrogate endpoints of survival in metastatic carcinoma
… quantified (1). Using an early proxy, or a surrogate endpoint, in place of the direct endpoint of overall survival (OS) could theoretically shorten the duration of RCTs and minimise the exposure of patients to ineffective or toxic treatments (2, 3). This thesis examined the relationship …
-
Impact of Informative Censoring on Statistics Used in the Validation of Surrogate Endpoints in Oncology
… (TTP), have been increasingly used as surrogate endpoints for overall survival (OS) in clinical trials in oncology. An issue occurs when clinical trials which demonstrated statistically significant treatment effect for the surrogate marker, shows no significant effect on the true …
-
The association between binary surrogate endpoints and time-to-event outcomes in two-arm clinical trials
… in breast cancer clinical trials as a surrogate endpoint for long-term survival outcome. We evaluated if and when a binary intermediate endpoint, like pCR, could be viewed as a surrogate endpoint for Event-Free Survival (EFS) and/or Overall Survival (OS) in neoadjuvant cancer treatment …
-
Search for valid surrogate endpoints: review of current evidence and development of practical strategies for surrogate evaluation
… pursuit of more quickly available treatments, surrogate endpoint evaluation has become a vital part of drug development. Despite the increasing uptake of surrogate endpoints and the large number of statistical methods proposed to evaluate a surrogate, there is still no consensus on how to …
-
Estimating optimal surrogate endpoints by machine learning and targeted minimum loss-based estimation in two-phase sampling studies
… application of TMLE in estimation of an optimal surrogate and implementation of inverse probability of censoring weighted targeted minimum loss-based estimation (IPCW-TMLE). In Chapter 1 we develop methodology for the estimation of optimal surrogates in randomized trials using targeted minimum …
-
Novel methods for network meta-analysis and surrogate endpoints validation in randomized controlled trials with time-to-event data
… methods, such as network meta-analysis and surrogate endpoints validation. Novel methods that rely on the difference in restricted mean survival times (RMST) would help addressing these issues. In this dissertation, I first developed a Bayesian network meta-analysis model using the …
-
Prognostic and surrogate markers for outcome in the treatment of pulmonary tuberculosis
… and can take over five years to complete. A surrogate marker for poor outcome (failure at end of treatment or recurrence following successful treatment), the established endpoint in such trials, could shorten trial duration and reduce trial size. Culture results after two months of treatment …
-
Strategies to accelerate evidence generation and application in colorectal cancer care
… electronic consenting (e-consenting) and surrogate endpoint use in RCTs as acceleratory strategies. First, OncoSim-CRC was used to support timely re-evaluation of national screening guidance due to rising rates of early-onset CRC by modelling the economic impacts of earlier screening. In a …
-
New methods for clinical trials with complex outcomes using surrogate and prioritized composite endpoints
In clinical trials, surrogate and composite endpoints can be used to increase the efficiency of the trial. The first section of this dissertation focuses on the validation of surrogate endpoints where current methodology encounters challenges in the presence of collinearity between the treatment …
-
Hazard assessment of a mixture of pharmaceuticals detected in the upper Tennessee River of Daphnia magna and the determination of riverine zooplankton assemblage as it relates to chitobiase activity
… in the Tennessee River using Daphnia- magna as a surrogate. Endpoints measured were time to first brood, reproduction, mortality, and number of neonates produced per adult reproduction day. Reproduction was the only endpoint that showed a significant effect. The LOEC of the pharmaceutical mixture …
-
Statistical tools for immune correlates analysis of vaccine clinical trial data
… correlates of protection (CoP) and can serve as surrogate endpoints in vaccine efficacy trials to accelerate the approval process. CoPs must be rigorously validated, and one method of doing so is through the controlled vaccine efficacy (CVE) curve, a function that represents the causal effect of …
-
Treatment Comparison with Survival and Non-survival Primary Endpoints
Multiple biomarkers (surrogate endpoints) are often used to predict the failure event, as well as to evaluate the effect of treatment. In biomarker researches, Behrens-Fisher problem is a nonparametric two sample comparison problem, which is vital due to its generality. In this thesis, we proposed …
-
Alternative Endpoints and Analysis Techniques in Kidney Transplant Trials
… on a composite outcome that consists of unequal endpoints that may generate misleading results. This thesis attempts to explore and apply methods to solve these issues and ultimately, improve kidney transplantation trials. We present a secondary analysis of the ACE trial in kidney transplant …
-
The Characterization of CACNA1A-related Hemiplegic Migraine
… therapies to manage and prevent HM events, surrogate endpoints were needed for future clinical trials. These goals were achieved through a systematic literature review, a longitudinal exploration of the disorder, and establishing a Disease Concept Model. This dissertation research has …
-
Ανάλυση κλινικών μελετών που υποστηρίζουν την υπό όρους άδεια κυκλοφορίας και την μετατροπή της σε κανονική άδεια κυκλοφορίας από τον Ευρωπαϊκό Οργανισμό Φαρμάκων (EMA) στην ογκολογία / Analysis of clinical trials supporting conditional marketing authorisation and its conversion to full marketing authorisation by the European Medicines Agency (EMA) in oncology
… πλήρως σε υποκατάστατα καταληκτικά σημεία (surrogate endpoints), με συχνότερο το Ποσοστό Αντικειμενικής Ανταπόκρισης (ORR). Η ποσοτική ανάλυση έδειξε σχετικό κίνδυνο χωρίς την Επιβίωση χωρίς Εξέλιξη της νόσου (HR PFS) στο 0,45 (0,37-0,55) για τα φάρμακα που αφορούν συμπαγείς όγκους με μέτρια …
-
A Single-Arm pilot study of BRodalumab in the treatment of Primary Sclerosing Cholangitis (SABR-PSC)
… change from baseline in liver biochemistry, surrogate markers of liver fibrosis, quantitative multi-parametric magnetic resonance imaging (MRI) and patient reported outcome measures (5-D Itch, CLDQ-PSC, PSC-PRO). Semi-structured interviews explored participant experiences. In parallel a …
-
Anatomy-aware hierarchical multiple instance learning for interpretable chronic obstructive pulmonary disease diagnosis from chest CT
… of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) cohort (n = 1,753). AnatoMIL achieved competitive performance relative to strong MIL baselines, including a more complex transformer-based approach, while providing anatomically structured regional representations. …
Page 1 of 2